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ReviewExperimental Genetic Approaches
to Addiction
Behavioral Manifestations of Drugs of Abuse
Addiction can be approached with the tools of genetic
analysis due to the establishment of behavioral para-
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digms that model different aspects of the progressionDepartment of Cell Biology
toward a pathological state. The endpoint of addictionDuke University Medical Center
involves a series of behavioral manifestations that areDurham, North Carolina 27710
variably evident, depending on the particular drug of
abuse (Woolverton and Johnson, 1992). All drugs of
abuse produce an acute response, which is most oftenDrugs of abuse are able to elicit compulsive drug-
characterized by enhanced arousal or euphoria. In ro-seeking behaviors upon repeated administration, which
dent studies, enhanced arousal is predominantly ob-ultimately leads to the phenomenon of addiction. Evi-
served as increased locomotor activity and stereotypicdence indicates that the susceptibility to develop ad-
behaviors. The ability to induce euphoria and reward isdiction is influenced by sources of reinforcement, vari-
usually studied using self-administration and condi-able neuroadaptive mechanisms, and neurochemical
tioned place-preference paradigms. In the self-adminis-changes that together lead to altered homeostasis of
tration test, the animal can be trained to control drugthe brain reward system. Addiction is hypothesized to
intake by nose poking (Kuzmin et al., 1992) or leverbe a cycle of progressive dysregulation of the brain
pressing (Caine et al., 1999), whereas conditioned placereward system that results in the compulsive use and
preference is based on the animal’s ability to pair re-loss of control over drug taking and the initiation of
warding drug with environmental cues in a two-chamberbehaviors associated with drug seeking (Koob et al.,
apparatus (Woolverton and Johnson, 1992).1998). The view that addiction represents a pathologi-
Tolerance refers to a situation where increasing dosescal state of reward provides an approach to identifying
of a drug become necessary to elicit an equivalent physi-the factors that contribute to vulnerability, addiction,
ological response. This behavioral manifestation is usu-and relapse in genetic animal models.
ally best exemplified when studying the antinociceptive
or rewarding effects of morphine (Di Chiara and North,Most of the advancements in our understanding of neu-
1992). Concurrent with tolerance and yet opposite inral processes leading to addiction come from animal
nature is the phenomenon of behavioral sensitization,studies. Any addictive drug of abuse works as a positive
whereby repeated intermittent exposure to a drug leadsreinforcer in virtually all vertebrate species. The fact that
to a progressive enhancement of the response to thatthe pathological endpoint can be achieved by pharma-
drug. Repeated administration of cocaine, for example,cological means in experimental animals makes addic-
produces more pronounced locomotor stimulation upontion easier to study than most of the other neuropsychi-
each consecutive exposure in many animals (Post andatric disorders. Still, the identification of the genes and
Rose, 1976). The coexistence of tolerance and sensitiza-proteins whose orchestrated function is responsible for
tion may first seem counterintuitive, but they probablycomplex behaviors is a formidable task, and drug-taking
reflect different aspects of drug action. For instance,behavior represents one of the most complex manifesta-
continuous cocaine infusion may lead to tolerance,tions of central nervous system (CNS) dysfunction. In
whereas intermittent exposure to the same drug leads
this review, we examine how experimental genetic ap-
to sensitization (Post and Rose, 1976; Inada et al., 1992;
proaches have been utilized to resolve the mechanisms
King et al., 1992; Izenwasser and French, 2002). While
of action of different drugs of abuse and the plastic it is difficult to assess cocaine sensitization in humans,
neuronal changes that underlie addiction. For more gen- it is an established phenomenon in animals and repre-
eral overviews of the neurobiology of addiction, we di- sents an enduring alteration in drug response. Psycho-
rect the reader to several excellent recent reviews (Wise, stimulant sensitization is discussed in more detail
1996; Nestler and Aghajanian, 1997; White and Kalivas, below.
1998; Koob et al., 1998; Di Chiara et al., 1999; Berke Another behavioral manifestation is physical depen-
and Hyman, 2000; Nestler, 2000, 2001a; Hyman and Ma- dence, which corresponds to an adaptive state of the
lenka, 2001). Here, we concentrate on a few, more spe- cells, circuits, or organ systems that are unmasked by
cific, topics: what are the most relevant behavioral para- abrupt cessation of drug exposure. This property is also
digms for evaluating mutant animals? How have the most often associated with opiate treatment, as opioid
candidate gene approach and development of knockout receptor antagonists induce a state of withdrawal that
mouse strains contributed to our understanding of the is noticeably unpleasant for the animal (Di Chiara and
subject? And, finally, how may the forward genetics North, 1992). A further behavioral consequence of drug
approach help us to identify new drug targets and ex- abuse is drug craving, the extent of which can be studied
plore truly novel realms of addiction mechanisms? Most by measuring drug-seeking behaviors (Littleton, 2000).
of the examples given are related to cocaine and other This manifestation may be common to most drugs of
psychostimulants, but the basic principles of the re- abuse. Compulsive drug taking, in which uncontrolled
search described can be applied to most drugs of abuse. drug self-administration continues despite noxious
physical and social consequences, is an advanced man-
ifestation of the addiction process. Lastly is the phenom-1Correspondence: caron002@mc.duke.edu
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enon of relapse; animals are trained to self-administer The search for potential candidate genes participating
in the development of addiction can be illustrated bydrug, the compulsive drug-taking behaviors are then
extinguished, and there is an increased tendency follow- using the example of behavioral sensitization (Woolver-
ton and Johnson, 1992; Wise, 1996; White and Kalivas,ing conditioned stimulus to reacquire the drug-taking
behavior (Littleton, 2000; Shalev et al., 2002). Some have 1998; Nestler, 2001a). In general, repeated administra-
tion of psychostimulants results in the initiation and in-argued that this behavior may be a more, if not the only,
relevant paradigm of drug addiction in humans. These tensification of the many biochemical and behavioral
manifestations that ultimately lead to the addicted state.different manifestations are likely to involve changes in
different neurotransmitter systems and neural circuits Behavioral sensitization is thought to be one of the early
manifestations of neuronal plasticity associated within the brain. An outstanding question in the field of drug
abuse is whether all of these behavioral manifestations chronic administration of a drug of abuse. The increased
sensitivity is often generalized across many drugs ofare directly associated with the addictive process or are
simply epiphenomena. abuse; for example, sensitization to cocaine engenders
an enhanced response to amphetamine and even toThe study of addiction using genetically manipulated
animals is still relatively young and has concentrated heroin. Sensitization to the locomotor stimulating effects
of psychostimulants is relatively simple to documentonly on few of the aforementioned paradigms. Acute
responses to psychostimulants or opiates have been in animal models and is one of the most reproducible
behavioral paradigms to study. Along with the acutestudied in many mutant mice, but less is known about
the genes contributing to tolerance, sensitization, and response, it is also probably the best studied in the
context of genetically manipulated animals. Sensitiza-reward. Genetic mechanisms regulating more complex
behaviors (such as relapse) are virtually unknown. In a tion induces long-lasting changes in the animal’s re-
sponse to a drug, enduring weeks and even monthsfew years from now, it should be possible to organize
such a review along the groups of genes that affect each after the last dose. While the biochemical basis of this
enhanced responsiveness is still not clear, sensitizationof these different behavioral manifestations. At present,
however, we feel that the reader is still best served by is believed to be associated with augmented intensity
of dopaminergic transmission (Pontieri et al., 1995;categorizing the existing literature according to different
levels of neurotransmitter signaling. White and Kalivas, 1998). For example, both increased
sensitivity of postsynaptic dopamine receptors (super-
sensitivity) and increased output of dopamine from pre-Neurotransmitters and Neural Circuits Involved
synaptic terminals have been postulated to contributein Addiction: Identifying Candidate Genes
to sensitization (Woolverton and Johnson, 1992; WhiteAlthough different classes of drugs of abuse have dif-
and Kalivas, 1998; Nestler, 2001a).ferent molecular targets in the CNS, they all lead to
Although dopamine represents a major neurotrans-increases in extracellular concentrations of the mono-
mitter system involved in addiction, it has become in-amine dopamine in certain regions in the brain. Dopa-
creasingly clear that other neurotransmitters can alsomine is a neurotransmitter that is involved in the control
significantly contribute to this pathological condition.of locomotion, cognition, emotion, affect, and reward
(Carlsson, 1987). In addition to the dopaminergic sys- For instance, psychostimulants are known to be potent
blockers not only of dopamine transporter (DAT), buttem, serotonergic and noradrenergic systems contrib-
ute, for example, to the effects of psychostimulants. also of the other monoamine transporters, namely the
norepinephrine (NET) and serotonin (SERT) transportersMoreover, the targets of other classes of abused drugs,
such as opiates, alcohol, and nicotine, encompass other (Amara and Kuhar, 1993). Recent evidence in genetically
engineered mice suggests that both the noradrenergicmajor neurotransmitter pathways, such as endogenous
opioids, the GABAergic system, and the cholinergic sys- and serotonergic systems may, in addition to the dopa-
minergic system, play significant modulatory roles intem, respectively. The brain regions thought to be most
involved in the reward, mood, cognition, and arousal determining the pharmacological and behavioral actions
of psychostimulants (Gainetdinov et al., 2002a). There-processes important for addiction are the nucleus ac-
cumbens (particularly the shell), the prefrontal cortex, fore, genes involved in the control of these neuro-
transmitter systems may also contribute to the neuronalthe ventral tegmental area (VTA)/substantia nigra region
where dopamine cell bodies are located, and other brain plasticity following chronic psychostimulant exposure.
Genes encoding autoreceptors governing release, syn-regions referred to as extended amygdala (Koob et al.,
1998; Di Chiara et al., 1999). It may become evident thesis, and firing rate (Roth and Elsworth, 1995); syn-
thetic and degradative enzymes; vesicular and plasmathat neural circuits are more important for reward and
compulsive drug intake rather than specific neurotrans- membrane transporters; and presynaptic heterorecep-
tors (glutamate, GABA, adrenergic, and serotonin) regu-mitter systems. For example, the brain reward system
that has been suggested to consist of extended amyg- lating dopamine are all candidate genes that could
contribute to changes in responsiveness. Similarly,dala is neurochemically a very heterogenous circuit.
Moreover, the manifestation of the addicted state is postsynaptic receptors, G protein subtypes, kinases,
effector proteins, cytoarchitectural proteins, and meta-hypothesized to involve brain circuits critical for any
compulsive behavior, such as the cortico-striatal-thala- bolic enzymes are also valid candidates for substrates
of supersensitivity (Nestler and Aghajanian, 1997). Othermic loop (Volkow and Fowler, 2000; Porrino and Lyons,
2000; Koob and Le Moal, 2001; Hyman and Malenka, candidate genes that could mediate this long-term plas-
ticity include transcription factors of the Jun/Fos family2001). Consequently, one might expect that a large num-
ber of individual genes might contribute to the manifes- (Nestler and Aghajanian, 1997; Nestler, 2001a; Nestler
et al., 2001). Lastly, recent electrophysiological experi-tations of the addictive state.
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ments have demonstrated that exposure to cocaine or DAT (Amara and Kuhar, 1993). Indeed, mice lacking the
DAT are hyperactive, resembling animals treated chroni-amphetamine induces long lasting neuronal plasticity in
cally with cocaine, and psychostimulants do not in-glutamate transmission in the corticostriatal pathway
crease further their locomotor activity (Giros et al., 1996;and VTA (Jones et al., 2000; Ungless et al., 2001; Thomas
Gainetdinov et al., 1999). However, these mice still self-et al., 2001; Beurrier and Malenka, 2002). Given the
administer cocaine, as well as show conditioned placeplethora of possible mechanisms that could underlie
preference for cocaine, indicating that the drug’s re-even a process as simple as sensitization, it is virtually
warding effects are not abolished (Rocha et al., 1998a;inconceivable that, using conventional approaches, one
Sora et al., 1998). Could this mean that DAT is not impor-could arrive at determining all of the relevant changes
tant for cocaine’s actions after all? The most likely an-associated with, or causative of, addiction.
swer is that it is still the most important mediator of
cocaine’s effects in wild-type animals, as well as in hu-Classical Genetic Approaches: Forward
man abusers (Amara and Kuhar, 1993). However, sinceand Reverse Genetics
cocaine also inhibits the uptake of other monoamines,Most of the knowledge available today about the molec-
these findings led to a proposal that its ability to elevateular events underlying the drug abuse process has come
synaptic serotonin or norepinephrine levels might con-long before the era of modern genetic research, using
tribute to its reinforcing effects. Although selective sero-classical pharmacological, biochemical, and behavioral
tonin (SERT) and norepinephrine (NET) inhibitors (suchapproaches. Identification of the principal targets of
as clinically used antidepressants) possess very little,drugs of abuse has prompted the use of an approach
if any, abuse potential in normal subjects, the lack ofreferred to as reverse genetics. Reverse genetics begins
cocaine’s primary target in DAT knockout mice mightwith a gene and then looks for the phenotype that results
have brought forth this subtle component of cocaine’sfrom mutations in that gene. Forward genetics proceeds
action. Moreover, one has to remember that the sus-from an altered phenotype and looks for the gene or
tained genetic blockade of DAT leads to a situationgenes responsible for that phenotype. In the context of
where cocaine-induced increase in the extracellular lev-addiction, forward genetics has been applied only to a
els of other monoamines is always coupled to a simulta-few organisms that demonstrate an altered response to
neous (albeit chronic) elevation of extracellular dopa-a drug of abuse. Below, we will highlight some of the
mine levels–basically mimicking the effect of cocaine inmost informative examples of each approach to demon-
wild-type animals. In other words, these studies do notstrate the power of genetic analysis to this field of
exclude the possibility that elevated dopamine levels inbiology.
the striatum and nucleus accumbens are still prerequi-
site for the rewarding effects of cocaine, even if seroto-Reverse Genetics: A Candidate Gene Approach
nin and norepinephrine also have roles.Many candidate genes have been studied by assessing
Studies in other monoamine transporter knockouts,the behavioral consequences of null mutations in mice.
however, suggest a more complicated interplay of theseOften, this approach has confirmed the postulated
transmitters. Mice lacking either SERT or NET displayinvolvement of drug targets. It has been used to demon-
enhanced cocaine place preference (Sora et al., 1998;strate the importance of -opioid receptors for the ac-
Xu et al., 2000a), and this behavior is even further accen-tions of morphine (Matthes et al., 1996), DAT for cocaine
tuated in mice lacking both transporters (Hall et al.,
and amphetamine (Giros et al., 1996; Jones et al., 1998),
2002). This result may indicate that genetic lack of SERT
NMDA receptors for phencyclidine (PCP) (Mohn et al.,
and/or NET leads to a cross-sensitized cocaine re-
1999), cannabinoid CB1 receptors for cannabinoids (Le- sponse through the same mechanism as chronic antide-
dent et al., 1999), and nicotinic acetylcholine receptors pressant treatment (Spyraki and Fibiger, 1981; Rossetti
for nicotine (Picciotto et al., 1998). Sometimes explora- et al., 1991; Xu et al., 2000a). It has also been suggested
tion beyond the obvious has produced interesting re- that serotonin and norepinephrine may mediate aversive
sults, indicating, for instance, that dopamine D2 recep- effects of cocaine. Elimination of these components in
tors (Maldonado et al., 1997; Elmer et al., 2002) and NET/SERT knockout mice would leave only cocaine’s
substance P receptors (Murtra et al., 2000) are also in- “pure” dopamine-mediated reward (Sora et al., 2001;
volved in the rewarding effects of morphine. Likewise, Hall et al., 2002). These explanations seem reasonable
the number of mutant mice known to display altered but leave the question of why, then, do DAT knockout
responses to the psychostimulants cocaine and am- mice display clear conditioned place preference not only
phetamine is already surprisingly large, especially con- for cocaine, but also for fluoxetine, a selective SERT
sidering the relatively simple pharmacology of these inhibitor, and nisoxetine, a selective NET inhibitor (Hall
drugs (Table 1). et al., 2002)?
Two unexpected characteristics of DAT knockout
Monoamine Transporters as Targets mice might provide insight to this apparent paradox.
of Psychostimulants First, both cocaine and fluoxetine actually lead to a dra-
Sometimes it is necessary to knock out several candi- matic calming effect in DAT knockout mice instead of
date genes one by one and to try to narrow down the increasing the already very high basal behavioral activity
potential list of the principal drug targets. Cocaine, am- of these animals, and this effect has been shown to be
phetamine, and many other psychostimulants are be- mediated by the activation of the brain serotonergic
lieved to produce their stimulating and addictive effects system (Gainetdinov et al., 1999). Maybe these animals,
mainly by increasing the extracellular levels of dopamine suffering from chronic hyperactivity and restlessness,
find SERT blockade caused by these drugs pleasantin the brain reward areas through the interaction with
Neuron
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because of its soothing effect instead of experiencing most surprising observation is the preserved reward in
further reward in a classical sense? This explanation dopamine transporter knockout mice. While these data
would not be in contradiction with somewhat aversive suggest that serotonergic and noradrenergic compo-
effects of acute SERT blockade in normal subjects. In nents are important to both the reinforcing and aversive
line with this hypothesis, mice lacking both DAT and effects of cocaine, they also demonstrate what powerful
SERT no longer display cocaine place preference (Sora tools genetically manipulated animals can be. This level
et al., 2001). of dissection of the pharmacological actions of cocaine
Cocaine, amphetamine, and the selective NET inhibi- had not been achieved prior to the availability of knock-
tor, reboxetine, were shown to increase extracellular out animals.
dopamine levels selectively in the nucleus accumbens,
but not in the dorsal striatum, of DAT knockout mice Dopamine Receptors Mediating Reward
(Carboni et al., 2001). This potentially explained why Studies in various dopamine receptor knockout mice
cocaine and nisoxetine were still rewarding in these have also strongly implicated the dopamine system in
mice and was proposed to reflect blockade of NET- drug abuse. D1 receptor is the most abundant dopamine
mediated dopamine uptake into noradrenergic nerve receptor in the brain, outnumbering the D2 receptor by
terminals. Heterologous uptake of dopamine via the NET 3-fold in the striatum. It was also the first dopamine
in brain areas with low DAT levels has been, in fact, receptor to be genetically altered in the mouse (Xu et
recently documented (Moron et al., 2002). More detailed al., 1994). As expected, cocaine did not cause hyperac-
investigation, however, ruled out any direct effects of tivity in D1 receptor knockout mice and also lost its
cocaine or selective NET inhibitors on dopamine clear- ability to induce the expression of various early genes,
ance in the nucleus accumbens in DAT knockout ani- such as c-fos and junB in the striatum of knockout mice
mals (Budygin et al., 2002). Instead, cocaine and NET (Moratalla et al., 1996). Stimulant-induced gene expres-
inhibitors seem to act outside the nucleus accumbens to sion is thought to participate in the plasticity underlying
increase dopamine release in mesolimbic dopaminergic long-term effects of drugs of abuse (Nestler et al., 2001;
neurons in DAT knockout mice. One possible circuit Nestler, 2001a), and D1 mutant mice indeed display re-
mediating the effects of norepinephrine on mesolimbic duced sensitizing response to repeated cocaine admin-
dopamine release may involve 1-adrenoceptors (Dar- istration (Xu et al., 2000b). Quite surprisingly, though,
racq et al., 1998). This may be, at least in part, a reason cocaine-induced reward assessed by conditioned place
why 1b-adrenoceptor knockout mice do not display preference is intact in D1 receptor knockout mice, sug-
cocaine-induced hyperactivity and reward (Drouin et al., gesting that signaling through other dopamine receptors
2002). However, a similar role of serotonin in the regula- is sufficient to preserve the reward mechanisms (Miner
tion of mesolimbic dopamine release cannot be ex- et al., 1995). Mice lacking the other member of the D1-
cluded. These findings suggest a role for the mesolimbic like receptor subfamily, the D5 dopamine receptor, have
dopamine system in the reinforcing effects of cocaine normal basal activity and display somewhat decreased
and other psychostimulants, even in DAT knockout response to D1-like receptor agonist SKF-81297 (Holmes
mice. One caveat, however, is that it is unclear whether
et al., 2001), but their response to psychostimulants has
a further increase in already dramatically elevated dopa-
not been yet reported.
mine levels can actually be rewarding.
The consequences of D2 receptor deletion may seem
The brain vesicular monoamine transporter (VMAT2)
even more puzzling. D2 receptor knockout mice do self-pumps monoamines, including dopamine, from the cy-
administer cocaine, can identify cocaine in a drug dis-toplasm into storage vesicles from which neurotransmit-
crimination test, and increase their locomotor activity inters are released into the synaptic cleft upon neural
response to cocaine (Caine et al., 2002; Chausmer etimpulse. Homozygous VMAT2 null mutant mice com-
al., 2002). Behavioral response in conditioned placepletely lack the ability to store catecholamines in the
preference for psychostimulants has not been reported.CNS and die soon after birth (Wang et al., 1997; Taka-
However, they fail to show conditioned place preferencehashi et al., 1997; Fon et al., 1997). However, heterozy-
to morphine (Maldonado et al., 1997) or to self-adminis-gote animals are viable and show a 25% decrease in the
ter this drug (Elmer et al., 2002), the effects of whichtissue content and 40% decrease in the basal extracellular
are presumably mediated mostly by -opioid receptorslevels of dopamine, resembling reserpine-treated animals
(Matthes et al., 1996). They also have lower propensity(Wang et al., 1997). This chronic deficiency of the endoge-
to self-administer ethanol (Risinger et al., 2000) and re-nous agonist leads to a denervation-type supersensitivity
spond at a lower rate than wild-type mice to food andof postsynaptic dopamine receptors. Accordingly, the
water reinforcers during training periods (Caine et al.,acute locomotor responses to psychostimulants in het-
2002; Elmer et al., 2002). This suggests that while D2erozygous mice are increased to a level that is compara-
receptor function is generally important for many naturalble to maximally sensitized, wild-type animals despite
and exogenous rewards (Kelley and Berridge, 2002), thesignificantly attenuated stimulated dopamine release
high potency of cocaine to act as a reinforcer may again(Wang et al., 1997). However, these animals still show
overcome this defect through other signaling pathways.reduced amphetamine-conditioned place preference
Mice lacking the other two members of the D2-like(Takahashi et al., 1997), suggesting that locomotor-stim-
receptor subfamily, the D3 and D4 dopamine receptors,ulating and -rewarding properties of a reinforcing drug
also show interesting phenotypes. Like D2 receptors, D3are not necessarily always correlated.
receptors are expressed both as pre- and postsynapticOverall, studies in monoamine transporter knockout
dopamine receptors (Diaz et al., 2000). D3 receptoranimals paint a picture of considerable complexity in
the actions of cocaine (Gainetdinov et al., 2002a). The knockout mice are slightly hyperactive in a novel envi-
Review
219
ronment, supersensitive to the locomotor effects of co-
caine, and display increased reward response to am-
phetamine as assessed by conditioned cue-preference
paradigm (Xu et al., 1997). In addition, basal extracellular
levels of dopamine are higher in mutant mice, which
may provide explanation to their heightened sensitivity
to psychostimulants (Koeltzow et al., 1998; Joseph et
al., 2002). D4 dopamine receptor knockout mice are
hypoactive in a novel environment but show supersensi-
tive locomotor responses to ethanol, cocaine, and meth-
amphetamine (Rubinstein et al., 1997).
Clearly, more studies are needed to investigate the
contribution of these receptors to the rewarding effects
of drugs of abuse. It is also worth noting that none of
the dopamine receptors have been found to be essential
for the rewarding effects of cocaine. Importantly, this
preservation of reward does not seem to be due to
compensatory upregulation of remaining dopamine re-
ceptor subtypes; D1 knockout mice show a minor (20%) Figure 1. Desensitization Mechanisms of G Protein-Coupled Re-
decrease in striatal D2 receptor binding, and deletions ceptors Can Affect the Efficacy of Many Drugs of Abuse
of D2, D3, or D4 seem to be devoid of any notable (A and B) Binding of the agonist (A) to the receptor (R), such as
compensatory changes in other dopamine receptors (Xu those for dopamine or opioids, leads to coupling of the receptor to
the G protein (G) and activation of the latter.et al., 1994, 1997; Rubinstein et al., 1997; Kelly et al.,
(C–E) In (C), G protein-coupled receptor kinases (GRK) can phos-1998). Instead, these findings indicate either the exis-
phorylate (P) receptors, either upon agonist stimulation or some-tence of redundancy in dopaminergic reward pathways
times under basal conditions. This leads to the binding of  arrestins
or the importance of other monoamines when dopamin- (ARR) and other accessory proteins to the receptor, uncoupling
ergic signaling is not intact. These hypotheses could be from G proteins, and finally to (D and E) internalization and either
tested using double or multiple knockouts, as has been recycling or degradation of the receptor (Claing et al., 2002; Pierce
and Lefkowitz, 2001).done in the case of monoamine transporter knockouts.
The data may also suggest that dopamine receptor an-
tagonists may not be promising targets for pharmaco-
therapy of cocaine addiction. On the other hand, partial messenger activation, and those that participate in long-
agonists of various dopamine receptors have shown term changes in neuronal plasticity (Figures 1 and 2).
some promise by counteracting the rapid elevations in G protein-coupled receptor kinases (GRKs) phos-
extracellular dopamine concentrations induced by psy- phorylate G protein-coupled receptors, leading to the
chostimulants and by having low abuse potential them- binding of  arrestins and other accessory proteins to
selves while still providing “substitution” to stimulant- the receptor; the uncoupling of the receptor from G
induced receptor activation (Pulvirenti and Koob, 2002). proteins; and, finally, endocytosis; thus promoting de-
sensitization of receptor signaling (Claing et al., 2002;
Pierce and Lefkowitz, 2001). Genetic deletion of GRKsIntracellular Signaling Mutants
and Addictive Drugs therefore presumably leads to supersensitive G protein-
coupled receptors. Which receptors will be the onesTraditional addiction research has focused largely on
release of endogenous neurotransmitters and the imme- affected depends on the colocalization with a given GRK
subtype (five of which, GRK2–GRK6, are found in thediate effect they, or the drugs mimicking them, have on
their membrane-bound receptors. However, especially brain) to the same neurons and brain regions, as well
as the possibility of biochemical interaction betweenfor the long-term effects of drugs of abuse, what hap-
pens inside the cell is probably more important than the kinase and the receptor. As an example, GRK6 is
widely expressed in the brain, including striatum andwhat happens between the brain cells (Nestler and Ag-
hajanian, 1997; Koob et al., 1998; Robbins and Everitt, cortical areas, and mice lacking GRK6 are supersensi-
tive to cocaine and amphetamine (Gainetdinov et al.,1999; Berke and Hyman, 2000; Hyman and Malenka,
2001; Nestler, 2001a). Stimulation of neurotransmitter 2002b). Dopamine release in these mice is unaffected,
and the supersensitivity to stimulants is most likely ex-receptors leads to signaling cascades involving G pro-
teins and their effectors, second messengers, protein plained by increased sensitivity of postsynaptic D2-like
dopamine receptors. These findings may open new ave-kinases and phosphatases, modification of intracellular
proteins, activation of transcription factors, and long- nues for the etiological research and pharmacological
treatment of disorders associated with aberrant dopa-lasting changes in the gene expression. When targeted
in the right cell and right region of the brain, any single minergic neurotransmission.
G proteins mediate the intracellular responses to thecomponent in this chain of events is likely to modify
either acute responses to drugs of abuse or the persis- stimulation of G protein-coupled receptors. G proteins
consist of three subunits, , , and . The specificity oftent changes they are capable of inducing. Candidate
genes for intracellular proteins that modulate drug re- receptor G protein interaction, as well as the appropriate
second messenger effector, is determined by the Gward can be sorted roughly into two classes: those that
mediate the initial response, such as receptor and second subunit. The GOLF subunit, named after its prominent
Neuron
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and has been thought to play a central role in the opiate
addiction and dependence as well. -opioid receptors
become rapidly desensitized upon agonist stimulation
and require higher and higher doses of the drug to pro-
duce similar cellular and behavioral responses. If the
long-term administration of opiates to a dependent sub-
ject is then abruptly ceased, severe physical and psy-
chological symptoms of withdrawal occur. Intuitively, it
would make sense that the precipitation of the opiate
withdrawal syndrome is caused by an altered homeo-
static state where desensitized opioid receptors are no
longer sufficiently stimulated in the absence of an exog-
enous agonist. However, studies in mice lacking  ar-
restin-2, a major component in the desensitization
mechanisms of G protein-coupled receptors (see Figure
1), have shown that opiate tolerance and dependence
are distinct processes (Bohn et al., 2000). In these ani-
mals, -opioid receptors will not become desensitized
after morphine administration nor will the animals be-
come behaviorally tolerant to the analgesic effects ofFigure 2. Interactions of Different Neurotransmitters in the Nucleus
morphine. Surprisingly, however, the opiate antagonistAccumbens Are Mostly Responsible for the Acute Effects as Well
naloxone given to mutant mice treated chronically withas Long-Term Neuronal Plasticity that Contribute to the Develop-
ment of Addiction morphine elicits withdrawal symptoms that are indistin-
guishable from those seen in wild-type animals. Thus,Medium spiny neurons in striatal brain regions receive, e.g., nigro-
striatal and mesolimbic dopaminergic innervation and corticostriatal changes other than -opioid receptor desensitization,
glutamatergic innervation. D1-like (D1) and D2-like (D2) dopamine such as long-term changes in gene expression and cy-
receptors stimulate and inhibit adenylyl cyclase (AC), respectively, clic AMP production, must be responsible for the with-
through specific G subunits of G proteins (GOLF and GO). Cyclic AMP drawal syndrome (Maldonado et al., 1996; Nestler,(cAMP) formed by AC activates cAMP-dependent protein kinases
2001a).(e.g., PKA-RII) and is itself inactivated by phosphodiesterases (e.g.,
Phosphodiesterases break down the cyclic AMP gen-PDE1B). PKA, in turn, regulates the ion conductivity of AMPA- and
NMDA-type glutamate receptors by phosphorylating (P) different erated by adenylyl cyclase, providing a way to terminate
receptor subunits. Ionic influx (Na, Ca2) through glutamate recep- the intracellular signaling. Modulation of their activity
tors regulates the membrane potential of the neuron and activates could also lead to changed homeostatic equilibrium
Ca2/calmodulin-dependent kinases (CaMKII/IV) via calmodulin where the certain degree of receptor stimulation results
(CaM). Both CaMK and PKA regulate gene expression by influencing
in increased or decreased intracellular response. Phos-the phosphorylation state of different transcription factors, such as
phodiesterase 1B is a subtype that, in the brain, localizesthe cAMP-responsive element binding protein (CREB). Phosphory-
to the regions innervated by the dopaminergic system,lated CREB activates the transcription of numerous genes having
cAMP-responsive element (CRE) in their promoter regions, such as like striatum (Polli and Kincaid, 1994), and theoretically
members of the Fos/Jun family of transcription factors (c-Fos, FosB, should work to dampen the dopaminergic signaling in
c-Jun etc.). Other known components relevant for these signaling the postsynaptic neuron. In line with this hypothesis,
pathways that are not shown include regulators of G protein signal-
phosphodiesterase 1B knockout mice are hyperactive ining (RGS proteins), members of the MAP kinase pathway, phospha-
a novel environment and show exaggerated locomotortase/kinase inhibitor DARPP-32, and several phosphatases that in-
responses to methamphetamine. Moreover, as ex-teract with it (e.g., PP-1 and calcineurin) (Nestler, 2001a; Greengard,
2001; Jiang et al., 2001; and other references within the text). pected, several protein kinase A substrates are hyper-
phosphorylated in response to D1 receptor agonists,
including DARPP-32 at threonine-34 and GluR1-subunit
expression in the olfactory epithelium, also mediates of the AMPA receptor at serine-845 (Reed et al., 2002).
the majority of D1 dopamine receptor-mediated adenylyl Somewhat surprising results were obtained with a
cyclase activation in the striatum (Zhuang et al., 2000). mouse strain lacking the RII-isoform of the cyclic AMP-
Like D1 receptor knockout mice, GOLF knockout mice dependent protein kinase (PKA) (Brandon et al., 1998).
are–paradoxically–slightly hyperactive but do not re- This isoform is enriched in striatum and is proposed to
spond to acute cocaine administration by increasing be one the most important PKA isoforms mediating the
their locomotor activity and also do not display induction effects of dopamine. However, acute stimulatory effects
of striatal c-Fos expression in response to cocaine. In of amphetamine and cocaine are intact and, even more
contrast, mice lacking the GZ subunit, which inhibits strikingly, the mutant mice show enhanced sensitization
adenylyl cyclase, show increased locomotor response to repeated amphetamine administration. In line with
to acute cocaine administration (Yang et al., 2000). How- reduced PKA activity, however, c-Fos induction caused
ever, the receptor(s) mediating this effect in the brain is by amphetamine–presumably mediated by the phos-
not known. phorylation of the transcription factor CREB (cyclic AMP
While repeated exposure to psychostimulants such responsive element binding protein) by PKA–is reduced
as cocaine leads to sensitized response, long-term in striatum. These results highlight the possibility that
treatment with opiates (such as morphine) also has in- part of the same plasticity involved in the development
verse consequences. The development of tolerance is of sensitization is also involved in tolerance against the
drug’s effects.a major problem in the clinical treatment of chronic pain
Review
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This same idea is suggested by results from mice havioral paradigms found that NMDA antagonists may
even enhance sensitization to dopaminergic drugseither lacking (Hiroi et al., 1997) or overexpressing (Kelz
et al., 1999) the transcription factor FosB. FosB, like (Tzschentke and Schmidt, 1998). Many of the inconsis-
tencies in the field probably arose from different dosesc-Fos, is expressed, e.g., in response to CREB phos-
phorylation by PKA or Ca2/calmodulin-dependent ki- and treatment regimens, and it became apparent that
genetic animal models could be invaluable for solvingnases (CaM kinases). However, while sustained stimula-
tion of this signaling pathway leads to a reduced this issue.
NMDA receptor-deficient mice, expressing only 5%induction of these early genes, the highly stable isoforms
of FosB, known as FosB, start to accumulate in the of the essential NR1 subunit of the NMDA receptor and
20%–25% of the NMDA receptor in different brain re-striatum. This accumulation of long-acting transcription
factors is believed to mediate some of the long-term gions (Mohn et al., 1999), were recently tested for their
responses to psychostimulants (Laakso et al., 2001,effects of psychostimulants and other psychotropic
drugs (Nestler et al., 2001). Mice lacking the fosB gene Soc. Neurosci. Abstr.). While the locomotor-stimulating
effects of acute cocaine administration were almostare supersensitive to cocaine and show enhanced co-
caine-conditioned place preference (Hiroi et al., 1997). abolished, repeated administration led to a fully sensi-
tized locomotor response and full rewarding effect inMoreover, mice overexpressing FosB in the nucleus
accumbens also show heightened response to cocaine a conditioned place-preference paradigm without any
compensatory increase in NMDA receptor expression.(Kelz et al., 1999). Taken together, these findings indi-
cate that fosB gene products may have both sup- This indicates that whatever plastic changes take place
during the development of sensitization, they do notpressing and enhancing influences on the effects of
psychostimulants. require intact NMDA receptor signaling. Surprisingly,
however, responses to acute amphetamine administra-One of the proteins downstream of FosB that may
participate in the negative feedback loop creating toler- tion at behavioral and gene expression levels were in-
tact. Since cocaine and amphetamine increase extracel-ance is cyclin-dependent kinase 5 (Cdk5). Cdk5 is
upregulated in response to chronic cocaine exposure, lular dopamine levels through different mechanisms
(inhibition of uptake and release from intracellular stor-as well as in FosB overexpressing mice (Bibb et al.,
2001). However, inhibiting the activity of Cdk5 by rosco- ages, respectively), it was first hypothesized that co-
caine’s lack of acute effects might be explained by thevitine leads to an enhanced sensitization to repeated
cocaine administration. This effect appears to be medi- reduced ability of cocaine to elevate extracellular dopa-
mine. However, striatal dopamine release induced byated through changes in the phosphorylation state of
phosphatase/kinase inhibitor DARPP-32. However, both acute cocaine and amphetamine administration
was preserved in mutant animals. These results suggestCdk5 has numerous substrates and identifying them
may provide clues for future targets of addiction therapy. an important role for corticostriatal glutamatergic neuro-
transmission in the acute effects of cocaine, whereasFurther substantiating the theoretical framework of in-
tracellular equilibrium between tolerance and sensitiza- amphetamine’s acute actions may be more directly me-
diated by dopamine. This pharmacodynamic differencetion, mice overexpressing CREB in the nucleus accum-
bens display aversion to the effects of cocaine, whereas (differential contribution of glutamatergic neurotrans-
mission) between cocaine and amphetamine may alsomice overexpressing a dominant-negative mutant of
CREB are supersensitive to its rewarding effects (Car- explain the dissociation between the acute behavioral
efficacy of the two drugs and their potency to elevatelezon et al., 1998). Eventually these mouse strains could
be used as tools for forward genetics approaches, and striatal dopamine levels in wild-type animals: amphet-
amine increases extracellular dopamine levels two tothe specific targets of the involved transcription factors
can thus be identified. five times more than cocaine yet is a less effective be-
havioral stimulant, indicating that additional (nondopa-
minergic) mechanisms must contribute to cocaine’sRole of Glutamatergic Transmission in Addiction
acute effects (Kuczenski et al., 1991). From the viewpointIn order to produce persistent behavioral patterns that
of addiction therapy, however, the results are somewhatmay lead to a relapse even years after the previous drug
disappointing and suggest that sensitization and rewardexposure, drugs of abuse have to induce very long-
may develop even in the absence of normal NMDA re-lasting changes in the brain of an addicted subject.
ceptor signaling.Because of the well-established role of the brain gluta-
Metabotropic glutamate receptor 5 knockout micemate system in learning and memory in general, the
were also found to be insensitive to the acute locomotor-same glutamatergic mechanisms have been postulated
stimulating effects of cocaine, but they did not self-to underlie the plasticity that explains addiction-related
administer it, even though they recognized food as anbehaviors (Berke and Hyman, 2000; Hyman and Ma-
effective reinforcer (Chiamulera et al., 2001). Perhapslenka, 2001). Consistent with this hypothesis, drugs that
more importantly, however, the same group–inspired byblock the NMDA-type glutamate receptors, such as MK-
the results in mutant mice–showed that the mGluR5801, were originally reported to block the development
antagonist MPEP blocks cocaine self administration inof psychostimulant sensitization (Wolf, 1998; Van-
wild-type animals. Of the many knockout mice testedderschuren and Kalivas, 2000) and were even proposed
to date in paradigms of drug addiction, the mGluR5as a possible treatment for cocaine addiction. However,
mutant mouse is the only line that fails to self-administerthis was somewhat contradictory to the fact that NMDA
psychostimulants. Given the striking phenotype of theseantagonists like PCP and ketamine are abused them-
selves, and some research groups using different be- animals, it would be interesting to determine whether it
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extends to other addictive drugs, such as morphine, and screening, or even microchip array analysis to find
genes whose expression changes with drug administra-nicotine, or ethanol.
Mice lacking the GluR1-subunit of AMPA-type gluta- tion. There are several genetic systems that can be used
in a phenotype-to-genotype screen for genes related tomate receptors are slightly hyperactive in a novel envi-
ronment, show supersensitive locomotor responses to addiction. There is evidence that, in addition to mice,
zebrafish and Drosophila can be amenable to pheno-morphine, develop less tolerance to its antinociceptive
effects, and have milder naloxone-precipitated with- typic screens for drugs of abuse. In this section, we will
focus on the potential and progress that has been madedrawal symptoms after repeated morphine administra-
tion than wild-type mice (Vekovischeva et al., 2001). in these three systems toward the identification of new
genes that underlie addiction.Furthermore, while context-independent sensitization
(repeated drug injections not paired with the final test
chamber) to the locomotor effects of morphine was Drosophila as a Model System
missing in these mice, they developed normal context- As a classic system for forward mutagenesis screens,
dependent morphine sensitization and even enhanced Drosophila has been useful, for example, in the identifi-
context-dependent sensitization to the stimulating ef- cation and characterization of genes that are necessary
fects of amphetamine. While these results suggest a for learning and memory. It may prove likewise useful
role for the AMPA receptors in both opioid and psycho- for drug-abuse research (Wolf, 1999). Fruit flies respond
stimulant responses, more studies are needed to fully to volatilized cocaine, nicotine, and ethanol with a range
understand and reconcile their possibly opposing of behaviors that parallels mammalian behaviors. For
involvement in the actions of these different drugs of cocaine and nicotine, there is a dose dependent shift
abuse. from hyperactivity (lower doses), to stereotyped groom-
Addiction studies in mice with genetically altered ing, to paralysis (highest doses) (McClung and Hirsh,
components of the brain glutamatergic system are still 1998; Bainton et al., 2000). Ethanol induces hyperactivity
sparse. However, recent electrophysiological work in at low doses and sedation at higher doses (Bainton
animals treated with cocaine and amphetamine has also et al., 2000). Flies with altered drug response can be
demonstrated the crucial role of glutamatergic neuro- selected based on their impaired ability to perform
transmission in the actions of these drugs. In VTA, even climbing activities or negative geotaxis (fly up). McClung
a short exposure to amphetamine blocks long-term de- and Hirsh (1998) have also demonstrated that flies sensi-
pression (LTD) in glutamatergic synapses onto dopa- tize to cocaine, with increased responsiveness develop-
minergic neurons (Jones et al., 2000), and single expo- ing after repeated exposures for 2 days.
sure to cocaine is able to induce long-term potentiation Drosophila screens have highlighted the importance
(LTP) of AMPA currents at the same synapses (Ungless of two biological pathways in the acute response to
et al., 2001). On the other hand, repeated cocaine expo- cocaine and ethanol. The first is the signal transduction
sure leading to sensitization induces long-lasting de- pathway mediated by cyclic AMP. Impaired regulation
pression of AMPA receptor-mediated glutamatergic of cAMP levels in a number of mutant fly lines confers
transmission at corticostriatal synapses in nucleus ac- enhanced sensitivity to ethanol (Moore et al., 1998). One
cumbens (Thomas et al., 2001; Beurrier and Malenka, of the first lines identified as such was cheapdate, which
2002). The role of NMDA receptors in this plasticity, was selected from a forward screen for altered ethanol
however, is not yet clear (Thomas et al., 2001; Beurrier response. Cheapdate was subsequently identified as an
and Malenka, 2002). Although this field is still young and additional hypomorphic allele of amnesiac, a memory
evolving, the existing literature already suggests that mutant that is deficient for an adenylyl cyclase stimulat-
similar glutamatergic mechanisms that underlie learning ing protein. Hypothesizing that reduced cAMP levels
and memory in general may participate in the addiction might be central to ethanol’s actions, Moore et al. tested
process. More mutants with glutamatergic deficits will other known mutants with altered cAMP regulation, in-
likely be screened in different drug-abuse paradigms in cluding rutabaga (calcium/calmodulin-sensitive AC),
the future. This will hopefully also direct the attempts dunce (cAMP-phosphodiesterase), and DCO (catalytic
to develop new therapeutic tools for the treatment of subunit of cAMP-dependent protein kinase). Rutabaga
addiction, for which drugs modulating excitatory neuro- and DCO mutations conferred enhanced ethanol sensi-
transmission hold a great promise. tivity, while dunce mutant flies had normal responses
to ethanol. Their results suggested that ethanol sensitiv-
ity is enhanced when cAMP signaling is impaired, butForward Genetics: A Phenotype Driven Approach
The theoretical framework that defines potential candi- is not suppressed by excess cAMP accumulation (as is
the case in dunce mutant flies). Within the context ofdate genes inherently limits reverse genetic approaches.
Gene targeting is best applied to answer the question genes of addiction, these studies are crucial for illumi-
nating ethanol’s still mysterious mechanism of action.of whether or not a gene is involved in an aspect of a
phenotype. Forward genetics may provide a valuable Cyclic AMP signaling has also been implicated in both
the acute and sensitized responses to cocaine in Dro-complementary approach to find new genes or sub-
strates that underlie addiction. Instead of mutating a sophila. Rather than taking a forward genetics ap-
proach, however, Park et al. (2000) studied the role ofcandidate gene, forward genetics proceeds from a phe-
notype of altered drug response and searches for the cAMP signaling in cocaine responsiveness by first iden-
tifying the Drosophila homolog of a gene and then char-genes responsible. In mice, such an approach could
entail quantitative trait loci (QTL) mapping to define sus- acterizing a line with an insertional mutation in that gene.
The pka-RII gene encodes a regulatory subunit of cAMP-ceptibility loci for drug sensitivity, random mutagenesis
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dependent protein kinase, and flies deficient in pka- and addiction. However, the same genetic approach
could theoretically be used with chemically induced mu-RII display a number of related phenotypes including
reduced sensitivity to both ethanol and cocaine and a tations to cover every allele in the genome. Ethylnitro-
sourea (ENU) has been used for many years to generatelack of sensitization to cocaine.
These flies also displayed alterations in their circadian point mutations in the mouse germline that result in null,
hypomorphic, and hypermorphic alleles (Justice et al.,rhythm locomotor activity, highlighting the second bio-
logical pathway that has been implicated in Drosophila 1999). In contrast to insertional mutagenesis that can
generate a single mutation per mouse, ENU has a muta-studies of addiction. Jay Hirsh and his colleagues have
found that four other circadian rhythm genes are re- tion rate that can effectively saturate the genome. Spe-
cific locus tests, which detect the frequency of null muta-quired for normal acute response and sensitization to
cocaine (Andretic et al., 1999). The mutants period, tions at seven loci in the mouse, suggest that ENU has
a forward mutation rate of as high as one null mutationclock, cycle, and doubletime fail to sensitize to cocaine,
perhaps due to the fact that they also fail to induce for every 650 genes (Hitotsumachi et al., 1985). Given
the ability to theoretically mutate one allele of everytyrosine decarboxylase expression after a sensitization
regimen. This thesis was further supported by findings gene in a population of as little as 300–900 mice, it is
not inconceivable to propose a genome-wide screenthat in the Drosophila mutant inactive, which harbors a
mutant tyrosine decarboxylase gene, sensitization to for mutations that affect some aspect of drug-taking
behavior. One principle advantage of such a screen iscocaine is also abolished (McClung and Hirsh, 1999).
This unexpected relationship between circadian rhythm, that like QTL mapping, it is an unbiased approach that
may uncover novel genes whose function is not knowntyrosine metabolism, and cocaine responsiveness may
illustrate best the potential for new theoretical con- or is not currently considered in drug abuse. However,
this is not to say that it is without limitations; such en-structs that could change our understanding of the pro-
cess of addiction. deavors require significant numbers of mice to map and
clone a gene (Vitaterna et al., 1994; King et al., 1997).These studies in Drosophila have translated to the
mouse. The two mouse homologs of period, mPer1 and Furthermore, if a screen focuses on one aspect of drug-
taking behavior, such as acute response to a drug, itmPer2, have been disrupted by gene targeting (Zheng
et al., 1999, 2001). Based on the correlation discovered may miss those genes that influence another aspect,
such as relapse potential. Therefore, the power of thisin Drosophila, these mutants were tested for cocaine
responsiveness, sensitization, and reward. Neither mu- forward genetic approach is also dependent on the qual-
ity of the phenotypic screen. For practical reasons,tant showed alterations in acute cocaine response, but
both showed striking and opposite alterations in sensiti- screens for complex behaviors (such as relapse or self
administration) are usually less realistic with such a largezation and conditioned place preference. Mice lacking
mPer1 fail to become sensitized or display conditioned numbers of animals.
place preference, whereas mice lacking mPer2 display
enhanced sensitization and reward (Abarca et al., 2002).
Gene Expression Profiling
If forward genetics is defined as a method that startsForward Genetics in the Mouse
with a phenotype and ends with a gene, another experi-Some of the first studies of the genetics of addiction
mental method that should be discussed in this contextusing mouse models capitalized on the identification of
is expression analysis using differential display and geneinbred strains displaying differential alcohol preference
chip microarrays. Using these technologies, changes in(McClearn and Rodgers, 1959). This observation has
the gene expression profile in relevant brain regionsbeen the starting point for a considerable amount of
(e.g., nucleus accumbens) have been assessed follow-research to identify quantitative trait loci (QTL) for vari-
ing chronic cocaine treatment in mice. The first studiesous aspects of alcohol and drug addiction. A QTL is the
using differential display have highlighted the role ofchromosomal location of a gene that contributes to the
some unexpected genes. A putative transcriptional reg-expression of a phenotype, such as enhanced ethanol
ulator (NAC-1), a G protein  subunit (rG1), and a tran-sensitivity. QTL mapping begins with two inbred strains
script encoding a new peptide transmitter or signalingthat differ substantially in some aspect of drug response.
molecule (CART) have all been isolated from the brainsThe recombinant inbred lines from these parental strains
of rats treated with cocaine or amphetamine (Cha et al.,display a continuum of phenotypes that can extend be-
1997; Wang et al., 1997; Douglass and Daoud, 1996).yond those of the original strains. A QTL is then identified
More recently, investigators have used gene chip mi-when a phenotype shows strong genetic linkage to a
croarrays to detect changes in gene expression. Evi-chromosomal region in several recombinant inbred
dence from this line of research has implicated NF-Blines. With improved interstrain polymorphism markers
(Ang et al., 2001) and cyclin-dependent kinase 5 (Bibb etand the completion of the murine genome sequence,
al., 2001) in signal transduction pathways that modulateQTL mapping is poised to reveal the identity of the alleles
cocaine’s behavioral effects and contribute to long-termthat confer altered responses to ethanol (see Crabbe and
neuronal changes associated with addiction. These re-Phillips, 1998, for review), morphine (Belknap and Crabbe,
sults are undoubtedly the first of many. While research1992), cocaine (Tolliver et al., 1994; Miner and Marley,
may focus initially on those genes with known function,1995; Phillips et al., 1998), amphetamine, and phencycli-
it should also assist in the functional annotation of thedine (Alexander et al., 1996).
novel genes whose expression changes in response toThe QTL method of genetic analysis tells us only what
naturally occurring alleles can influence drug response drugs of abuse.
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Zebrafish as a Potential Model System ment of addiction. However, the challenge will be to
identify those genes that are involved in the extinction ofZebrafish, as a relatively new genetic system, has obvi-
ously not been used extensively in the field of drug addiction. In order to find therapeutic targets for human
drug addicts, the ideal mutant should develop an addic-addiction. However, there are preliminary reports sug-
gesting that they can be used for screens of the acute tion but then be more resilient to relapse.
Clearly, the benefit of these studies ought to be theresponse to ethanol (Gerlai et al., 2000) and cocaine
(Darland and Dowling, 2001). Gerlai et al. describe a eventual application to human drug addiction. One ap-
plication may be the identification of susceptibility lociseries of behaviors that are altered by ethanol exposure
in a dose-dependent manner, including activity, social in humans. Genes central to addiction in animal models
may have differing alleles in humans, and allelic differ-behavior, and light-dark/top-bottom preferences. Al-
though their report did not extend to screening muta- ences may explain in part why some people are more
susceptible to addiction than others. The earliest andgenized fish, it established the feasibility of future
screens to assess acute response to ethanol. In a differ- best-known example of this is the identification of the
Taq1 A1 allele of the human D2 dopamine receptor geneent study, Darland and Dowling performed a chemical
mutagenesis screen to study cocaine responsiveness; as a risk factor for alcoholism (Blum et al., 1990). How-
ever, it has proven extremely difficult to define the genesconditioned place preference was measured by placing
a cocaine-saturated wick in one side of a tank divided responsible for polygenic disorders, which most neuro-
psychiatric disorders (like addiction) undoubtedly are.by a perforated wall. While most fish display preference
for the cocaine-treated side of the tank, three mutant When one gene contributes only 1%–5% to the total
risk, half of which is environmental instead of genetic,fish lines were identified that showed no preference:
dumbfish (dum), jumpy (jpy), and goody-two-shoes (gts). one quickly realizes the difficulty of the task at hand
(Comings, 1998; Duaux et al., 2000; Nestler, 2001b). Still,The spatial learning and memory of these fish were
tested in a simple T maze assay, with dum showing at some future date, perhaps people with an identified
susceptibility to addiction would be aware of their ge-impaired performance but jpy and gts showing normal
performance. These studies show promise for uncov- netic predisposition and would be less likely to engage
in experimental drug use. But more desirable than thisering genes related to addiction that may be evolution-
arily conserved among vertebrates. scenario would be the identification of genes that pre-
vent relapse in humans. It is only after an addiction
is established and reward pathways are altered whenChallenges and Future Directions for the Genetics
patients do seek to cease drug use. Ideally, geneticof Addiction
studies in animals should help identify therapeutic tar-The collection of transgenic mice that have an altered
gets to assist in relapse prevention. While it will be chal-response to at least one drug of abuse has grown quite
lenging to determine which genes or changes arelarge. The question remains as to whether all of the
uniquely responsible for addiction, understanding thegenes thus implicated are in fact responsible for the
process in greater detail should lead to novel ap-neuronal plasticity that leads to the initiation and mainte-
proaches to develop therapeutic or preventative inter-nance of the addictive state. One way to address this
ventions.question is to identify those mice that display altered
response to several classes of addictive drugs. This
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